Yearbook

UK’s pharma regulatory scene reckons with changes in 2023

Pharma breakthroughs: 10 novel drug approvals that made headlines in 2023

2023 review: the themes shaping year in the healthcare sector

Humira biosimilars set the stage for long-awaited 2023 US launches

Inside the hunt for an Alzheimer’s disease vaccine

Pathbreakers: The journey of first generics

NASH drugs race to cross the finish line

Fighting AMR with a value and subscription model

Cancer treatment uncertainty: European nations struggle with drug shortages

Why are haemophilia gene therapies so expensive?

Top themes for the healthcare sector in 2024